These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11711500)

  • 1. Effects of antisense oligodeoxynucleotide targeting of the alpha(2B)-adrenergic receptor messenger RNA in the central nervous system.
    Kintsurashvili E; Gavras I; Johns C; Gavras H
    Hypertension; 2001 Nov; 38(5):1075-80. PubMed ID: 11711500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats.
    Shenouda SM; Johns C; Kintsurashvili E; Gavras I; Gavras H
    Am J Hypertens; 2006 Nov; 19(11):1135-43. PubMed ID: 17070424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central alpha2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertension.
    Kintsurashvili E; Johns C; Ignjacev I; Gavras I; Gavras H
    J Hypertens; 2003 May; 21(5):961-7. PubMed ID: 12714871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense inhibition of the brain kallikrein-kinin system.
    Madeddu P; Parpaglia PP; Glorioso N; Chao L; Chao J
    Hypertension; 1996 Dec; 28(6):980-7. PubMed ID: 8952586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in transgenic mice with brain-selective overexpression of the alpha(2B)-adrenoceptor.
    Kintsurashvili E; Shenouda S; Ona D; Ona L; Ahmad S; Ravid K; Gavras I; Gavras H
    Am J Hypertens; 2009 Jan; 22(1):41-5. PubMed ID: 18989257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension.
    Makaritsis KP; Handy DE; Johns C; Kobilka B; Gavras I; Gavras H
    Hypertension; 1999 Jan; 33(1):14-7. PubMed ID: 9931075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice.
    Makaritsis KP; Johns C; Gavras I; Gavras H
    Hypertension; 2000 Feb; 35(2):609-13. PubMed ID: 10679505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood.
    Peng JF; Kimura B; Fregly MJ; Phillips MI
    Hypertension; 1998 Jun; 31(6):1317-23. PubMed ID: 9622148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central plasmid antisense administration reduces blood pressure inhibiting alpha2B adrenoceptor gene expression in spontaneously hypertensive rats in vivo.
    Triantafyllidi H; Kintsurashvili E; Johns C; Gavras I; Gavras H
    Hellenic J Cardiol; 2006; 47(3):144-9. PubMed ID: 16862820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of alpha2A-adrenergic receptor expression in neonatal rat brain by RNA interference or antisense oligonucleotide reduced anxiety in adulthood.
    Shishkina GT; Kalinina TS; Dygalo NN
    Neuroscience; 2004; 129(3):521-8. PubMed ID: 15541874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin antisense injected intraventricularly decreases blood pressure in spontaneously hypertensive rats.
    Kubo T; Ikezawa A; Kambe T; Hagiwara Y; Fukumori R
    Brain Res Bull; 2001 Sep; 56(1):23-8. PubMed ID: 11604244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype.
    Makaritsis KP; Johns C; Gavras I; Altman JD; Handy DE; Bresnahan MR; Gavras H
    Hypertension; 1999 Sep; 34(3):403-7. PubMed ID: 10489385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adrenergic receptor and knockout mouse: 2). Alpha adrenergic receptor knockout mouse].
    Mizobe T
    Masui; 2001 Jan; 50(1):12-9. PubMed ID: 11211741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New beta-blocker: prolonged reduction in high blood pressure with beta(1) antisense oligodeoxynucleotides.
    Clare Zhang Y; Kimura B; Shen L; Phillips MI
    Hypertension; 2000 Jan; 35(1 Pt 2):219-24. PubMed ID: 10642301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats.
    Kagiyama S; Varela A; Phillips MI; Galli SM
    Hypertension; 2001 Feb; 37(2 Pt 2):371-5. PubMed ID: 11230302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central alpha 2-adrenoceptors and blood pressure regulation in the rat.
    Nunes JP
    Eur J Pharmacol; 1995 May; 278(2):183-5. PubMed ID: 7672004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone dependence of salt-induced hypertension in Sabra rats and role of renal alpha(2)-adrenoceptor subtypes.
    Khalid M; Ilhami N; Giudicelli Y; Dausse JP
    J Pharmacol Exp Ther; 2002 Jan; 300(1):43-9. PubMed ID: 11752095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antisense oligodeoxynucleotide to the alpha2A-adrenoceptors on the plasma corticosterone level and on elevated plus-maze behavior in rats.
    Shishkina GT; Kalinina TS; Sournina NY; Saharov DG; Kobzev VF; Dygalo NN
    Psychoneuroendocrinology; 2002 Jul; 27(5):593-601. PubMed ID: 11965357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats.
    Gyurko R; Tran D; Phillips MI
    Am J Hypertens; 1997 May; 10(5 Pt 2):56S-62S. PubMed ID: 9160782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.